Immunovant

Immunovant, Inc. is a clinical-stage immunology company developing targeted therapies for people with autoimmune diseases.

1 documented relationship

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Sandeep Kulkarni, M.D.EmploymentImmunovant
^{3Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officermarkets.financialcontent.com}^{4Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officerfinance.yahoo.com}
Position or object indicated by the source: “Chief Operating Officer”.

Sources

1.
Immunovant, Inc.
Web pageimmunovant.com
Institutional context: this homepage does not replace a specific source for a claim.
View original ↑ Back to text
2.
For Investors
Web pageimmunovant.com
View original ↑ Back to text
3.
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
Web pagemarkets.financialcontent.com
View original ↑ Back to text
4.
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
Web pagefinance.yahoo.com
View original ↑ Back to text